TY - JOUR
T1 - Effect of the natural sweetener xylitol on gut hormone secretion and gastric emptying in humans
T2 - A pilot dose-ranging study
AU - Meyer-Gerspach, Anne Christin
AU - Drewe, Jürgen
AU - Verbeure, Wout
AU - Le Roux, Carel W.
AU - Dellatorre-Teixeira, Ludmilla
AU - Rehfeld, Jens F.
AU - Holst, Jens J.
AU - Hartmann, Bolette
AU - Tack, Jan
AU - Peterli, Ralph
AU - Beglinger, Christoph
AU - Wölnerhanssen, Bettina K.
PY - 2021
Y1 - 2021
N2 - Sugar consumption is associated with a whole range of negative health effects and should be reduced and the natural sweetener xylitol might be helpful in achieving this goal. The present study was conducted as a randomized, placebo-controlled, double-blind, cross-over trial. Twelve healthy, lean volunteers received intragastric solutions with 7, 17 or 35 g xylitol or tap water on four separate days. We examined effects on: gut hormones, glucose, insulin, glucagon, uric acid, lipid profile, as well as gastric emptying rates, appetite-related sensations and gastrointestinal symptoms. We found: (i) a dose-dependent stimulation of cholecystokinin (CCK), active glucagon-like peptide-1 (aGLP-1), peptide tyrosine tyrosine (PYY)-release, and decelerated gastric emptying rates, (ii) a dose-dependent increase in blood glucose and insulin, (iii) no effect on motilin, glucagon, or glucose-dependent insulinotropic peptide (GIP)-release, (iv) no effect on blood lipids, but a rise in uric acid, and (v) increased bowel sounds as only side effects. In conclusion, low doses of xylitol stimulate the secretion of gut hormones and induce a deceleration in gastric emptying rates. There is no effect on blood lipids and only little effect on plasma glucose and insulin. This combination of properties (low-glycemic sweetener which stimulates satiation hormone release) makes xylitol an attractive candidate for sugar replacement.
AB - Sugar consumption is associated with a whole range of negative health effects and should be reduced and the natural sweetener xylitol might be helpful in achieving this goal. The present study was conducted as a randomized, placebo-controlled, double-blind, cross-over trial. Twelve healthy, lean volunteers received intragastric solutions with 7, 17 or 35 g xylitol or tap water on four separate days. We examined effects on: gut hormones, glucose, insulin, glucagon, uric acid, lipid profile, as well as gastric emptying rates, appetite-related sensations and gastrointestinal symptoms. We found: (i) a dose-dependent stimulation of cholecystokinin (CCK), active glucagon-like peptide-1 (aGLP-1), peptide tyrosine tyrosine (PYY)-release, and decelerated gastric emptying rates, (ii) a dose-dependent increase in blood glucose and insulin, (iii) no effect on motilin, glucagon, or glucose-dependent insulinotropic peptide (GIP)-release, (iv) no effect on blood lipids, but a rise in uric acid, and (v) increased bowel sounds as only side effects. In conclusion, low doses of xylitol stimulate the secretion of gut hormones and induce a deceleration in gastric emptying rates. There is no effect on blood lipids and only little effect on plasma glucose and insulin. This combination of properties (low-glycemic sweetener which stimulates satiation hormone release) makes xylitol an attractive candidate for sugar replacement.
KW - Appetite-related sensations
KW - Blood lipids
KW - Gastric emptying
KW - Gastrointestinal symptoms
KW - Gut hormones
KW - Natural sweeteners
KW - Uric acid
KW - Xylitol
U2 - 10.3390/nu13010174
DO - 10.3390/nu13010174
M3 - Journal article
C2 - 33429977
AN - SCOPUS:85099031799
VL - 13
JO - Nutrients
JF - Nutrients
SN - 2072-6643
IS - 1
M1 - 174
ER -